# Survival Outcomes and Tumor Molecular Profile Following Bicalutamide Neoadjuvant Therapy

> **NCT00418080** · PHASE2 · COMPLETED · sponsor: **University of L'Aquila** · enrollment: 86 (—)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** bicalutamide

## Key facts

- **NCT ID:** NCT00418080
- **Lead sponsor:** University of L'Aquila
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 86 (—)
- **Last updated:** 2007-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00418080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00418080, "Survival Outcomes and Tumor Molecular Profile Following Bicalutamide Neoadjuvant Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00418080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*